Connect with us
DAPA Banner

Crypto World

Why Markets Care About This White House Drug Site

Published

on

Why Markets Care About This White House Drug Site

President Donald Trump this week launched TrumpRx, a government-backed platform aimed at lowering prescription drug prices for Americans paying out of pocket. While the announcement initially raised concerns about pricing pressure, financial markets have delivered a clear response.

Major pharmaceutical stocks rallied on February 6, signaling that investors do not see TrumpRx as a near-term threat to earnings. That reaction also matters for broader markets, including crypto, because it shapes overall risk sentiment.

Sponsored

What TrumpRx Actually Is

TrumpRx is a pricing and discount portal, not a price-control regime. The platform lists dozens of commonly used drugs and directs users to discounted cash prices offered voluntarily by drugmakers and pharmacies.

Crucially, it targets cash-paying and uninsured consumers. It does not affect insurance-negotiated prices, Medicare reimbursement formulas, or long-term supply contracts, which make up the bulk of US pharmaceutical revenue.

TrumpRx Website

But Investors Aren’t Panicking About Drug Profits

Markets are signaling that TrumpRx trims the edges of pricing, not the core. Most pharmaceutical revenue comes from insured and institutional channels that remain untouched by the program.

Sponsored

Advertisement

For dominant players in high-demand categories like weight-loss and specialty drugs, pricing power remains strong. 

In some cases, lower cash prices may even boost volumes without materially hurting margins.

US Big Pharma Stocks Actually Increased After TrumpRx Launch. Source: TradingView

Voluntary Discounts, Not Forced Controls

Another key factor is structure. Participation in TrumpRx is voluntary and tied to broader trade and supply-chain cooperation, including tariff relief.

Sponsored

For global drugmakers, reduced trade and regulatory risk can offset limited pricing concessions. That trade-off helps explain why the sector moved higher instead of lower.

Advertisement

What This Means For Broader Markets

The pharma rally sends a wider signal. Investors are not pricing in aggressive government intervention or profit-destroying regulation.

That matters for equities and crypto alike. When policy actions appear contained and predictable, risk appetite stabilizes across markets.

Sponsored

Crypto Cares, Even Indirectly

TrumpRx has no direct link to digital assets. However, crypto remains highly sensitive to policy uncertainty and financial conditions.

Advertisement

By failing to trigger a regulatory shock or worsen inflation expectations, TrumpRx reduces the chance of a hawkish policy response from the Federal Reserve. Stable rate expectations ease pressure on volatile assets like Bitcoin and Ethereum.

Markets are treating TrumpRx as a political signal, not a systemic shock. The positive reaction in pharma stocks shows investors see the policy as narrow, voluntary, and economically contained.

For crypto and risk assets, the takeaway is simple. TrumpRx does not tighten financial conditions or raise regulatory risk. 

Instead, it supports a backdrop of policy stability that allows markets to focus on liquidity, rates, and fundamentals rather than fear.

Advertisement

Source link

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Crypto World

Bitcoin Breaks 5-Month Losing Streak With $68K March Close: What’s Next?

Published

on

Cryptocurrencies, Bitcoin Price, Markets, BTC Markets, Price Analysis, Market Analysis

Bitcoin (BTC) closed March in green, ending the longest monthly losing streak since 2018. Data suggests that the coming months may prove to be profitable for BTC.

Key takeaways:

  • Bitcoin ended March 2% higher, marking the first green monthly close in six months.

  • A similar streak in 2018/2019 led to an over 316% BTC price rebound over five months.

  • Bitcoin price faces stiff resistance at $70,000-$72,000, where key trend lines converge.

Past multi-month downtrends were followed by 300% price gains

Historical price data from CoinGlass confirms Bitcoin printed its first green monthly candle in six months, closing March 2% higher after five straight months of losses.

“This is a massive dose of hopium,” analyst Ash Crypto said in an X post on Wednesday.

Advertisement

The analyst was referring to a possible shift in momentum, which might lead to a sustained recovery, as seen in previous cycles.

Related: Crypto Fear & Greed Index stuck on ‘extreme fear,’ but is there a silver lining?

The last time this happened was in 2018/2019 when BTC closed February 2019 in green, after six consecutive red months, as shown in the figure below.

This led to a reversal with over 300% returns the following five months, as Bitcoin recovered from the 2018 bear market.

Advertisement

“Last time BTC dumped 6 months in a row, it pumped the following 5 months in a row that came after!” trader Satoshi Flipper said in a Wednesday post on X.

Cryptocurrencies, Bitcoin Price, Markets, BTC Markets, Price Analysis, Market Analysis
Bitcoin monthly percentage returns. Source: CoinGlass

If history repeats itself, the reversal may continue in April, suggesting that BTC price may have bottomed at $60,000.

Bitcoin’s bullish monthly close is a ”catalyst for fresh inflows into early April,” Trader Caleb said, adding:

“April starts with momentum.”

Bitcoin has a well-established tendency for significant price swings in April.

Since 2013, April has been a green month for eight of the past 13 years, with average returns of about 12.2%

Advertisement

However, Bitcoin also tends to move in the opposite direction to March in April, and this is true for nine out of the past 13 years. 

In recent years, Bitcoin dropped in April after closing March in green, three out of four times between 2021 and 2024. 

Therefore, while the end of past multi-month drawdowns suggests a rebound is due, data demonstrates that BTC price could also slide in April.

Watch these Bitcoin price levels next

Data from TradingView shows BTC price up 2.5% on the day to trade at $68,470 as the $69,000-$70,000 resistance remains in place.

Advertisement

Analysts expect Bitcoin’s range-bound price action to continue for longer, with important price levels to look for in case of a breakout. 

These include the $70,000-$72,000 supply zone, coinciding with the 50-day simple moving average (SMA), the 50-day exponential moving average (EMA) and the 1w–1m cohort cost basis

This is also where investors acquired approximately 650,000 BTC, marking a potential point of sell pressure, according to the cost-basis distribution data from Glassnode.

Breaking above this level could see BTC/USD revisit the $76,000 range high and eventually the $80,000 psychological level.

Advertisement
BTC/USD daily chart. Source: Cointelegraph/TradingView

Zooming out, trader Sheldon Diedericks said Bitcoin could “push into resistance” at $83,000 on the monthly time frame, a key support level from April 2025. The 200-day EMA is also close to this area.

BTC/USD monthly chart. Source: X/Sheldon Diedericks

On the downside, the 200-week EMA at $68,300 and the 200-week SMA at $59,400 remain key levels to watch. Below that, the next major level is Bitcoin’s realized price around $54,000.

As Cointelegraph reported, Bitcoin’s bear market bottom could be formed once BTC price drops toward or below its realized price.